Company intelligence / Profile preview

Cygnus Biotechnology

Leland, North Carolina, United Statesshadowrunseattle.wikidot.com ↗

Ownership: Private
Development stage: Other

Overview

Cygnus Technologies is an industry leader in host cell protein and impurity detection assays. Their products are widely used by biopharmaceutical manufacturers to ensure the safety of biologic drugs prior to clinical trials and commercial release. They recently partnered with Dyadic International to launch a first-in-class C1 HCP ELISA assay supporting advanced protein production platforms.

Modalities: Monoclonal antibodyProteinGene therapyVaccinePlasma derivatives
Industry: Protein Biomarker Diagnostics

Partnerships

Dyadic International Inc.

Beyond the preview

Go deeper on Cygnus Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cygnus Biotechnology.

Explore the full profile